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ABSTRACT 
Medicinal plants have been used by the population for several years for treatment and prevention 
of diseases. Folk knowledge of plants can serve as information on efficacy and toxicity of these 
vegetables. Many people think that because they are natural, plants are free of side effects and 
interactions with the medicines that they used. The present study had as objective to conduct an 
ethnopharmacological survey of medicinal plants in the Brazilian cities of Manoel Viana, RS, and 
São Francisco de Assis, RS, and to evaluate their possible drug interactions. The present work 
was carried out through interviews, where individuals were questioned about the use of plants and 
of medicines. Of the 205 participants interviewed, most were women (79%), approximately 98% 
used medicinal plants, and approximately 82% reported the presence of chronic diseases in their 
communities and the use of pharmaceuticals to treat them. The medicinal plants cited most often 
were Achyrocline satureioides, Peumus boldus Molina, Chamomilla recutita, Cymbopogon 
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citratus (DC), and Melissa officinalis L, while the most frequent chronic diseases mentioned were 
arterial hypertension, depression, dyslipidemia, and diabetes mellitus. The drugs cited most often 
were hydrochlorothiazide, losartan, simvastatin, and metformin, and the results of the study 
revealed numerous plant–drug interactions. Results of the study indicate a profile of the use of 
medicinal plants and synthetic drugs used by the population of Manoel Viana, RS, and São 
Francisco de Assis, RS, Brazil.  
Keywords: Drug interactions; Ethnopharmacology; Medicinal herbs; Phytotherapy. 
RESUMO 
Plantas medicinais têm sido usadas pela população há vários anos para tratamento e prevenção de 
doenças. O conhecimento popular das plantas pode servir como informação sobre a eficácia e 
toxicidade destes vegetais. Muitas pessoas pensam que, por serem naturais, as plantas são livres 
de efeitos colaterais e interações com os remédios que usavam. O presente estudo teve como 
objetivo realizar um levantamento etnofarmacológico de plantas medicinais nas cidades 
brasileiras de Manoel Viana, RS, e São Francisco de Assis, RS, e avaliar suas possíveis interações 
medicamentosas. O presente trabalho foi realizado por meio de entrevistas, onde os indivíduos 
foram questionados sobre o uso de plantas e de medicamentos. Dos 205 participantes 
entrevistados, a maioria era de mulheres (79%), aproximadamente 98% usavam plantas 
medicinais, e aproximadamente 82% relataram a presença de doenças crônicas em suas 
comunidades e o uso de medicamentos para tratá-las. As plantas medicinais mais citadas foram 
Achyrocline satureioides, Peumus boldus Molina, Chamomilla recutita, Cymbopogon citratus 
(DC) e Melissa officinalis L, enquanto as doenças crônicas mais citadas foram hipertensão 
arterial, depressão, dislipidemia e diabetes mellitus. As drogas mais citadas foram 
hidroclorotiazida, losartan, sinvastatina e metformina, e os resultados do estudo revelaram 
inúmeras interações planta-droga. Os resultados do estudo indicam um perfil do uso de plantas 
medicinais e drogas sintéticas utilizadas pela população de Manoel Viana, RS, e São Francisco 
de Assis, RS, Brasil. 
Palavras-chave: Etnofarmacologia; Ervas medicinais; Fitoterapia; Interações medicamentosas. 
 
1 INTRODUCTION 
Medicinal plants have been used for therapeutic purposes since antiquity and 
continue to be used today to prevent, cure, and treat diseases (Wachtel–Galor and Benzie, 
2011). Even with the evolution of the pharmaceutical industry, the culture of the use of 
plants and knowledge about their benefits have been retained, which demonstrates their 
importance and effectiveness (Niehues, 2011).  
 Because medicinal plants originate in nature, many people believe that they are 
free of chemical components as well as side effects and can thus be used without 
restriction or attention to dosage (Mengue, 2001). However, medicinal plants are not free 
of toxins, and their toxic effects can directly influence the pharmacotherapy of patients 
by intensifying or reducing the effects of drugs (Capasso et al., 2000). Moreover, 
medicinal plants are not free of side effects (Oliveira, 2007), for the compounds present 
in plants produce reactions in the body that can be positive or negative for patients 
(Zancanaro, 2007). Importantly, when medicinal plants are combined with 
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pharmaceuticals to treat chronic diseases, the risk of sometimes dangerous side effects 
increases (Futuro et al., 2004; Veiga Júnior et al., 2005; Londrina, 2006). 
Ethnopharmacology is a science that helps to identify and describe medicinal 
plants and their therapeutic uses. Ethnopharmacology should be used not only to 
understand the therapeutic effects of plants, however, but also to promote knowledge of 
plant–drug interactions to ensure that they do not harm the health of users (Simões et al., 
2010). Consequently, ethnopharmacological studies involve not only recording the use of 
medicinal plants but also identifying how they are administered, as well as collecting 
information about the people who use them and the possible influences of such usage on 
the realities of communities (Coelho et al., 2005, Simões et al., 2010). 
Although several ethnopharmacological studies have been conducted in the 
Brazilian state of Rio Grande do Sul (Ritter, 2002; Barros, 2007; Battisti, 2013), none 
have been performed in the cities of Manoel Viana or São Francisco de Assis. Given the 
high use of medicinal plants in those cities and to deepen knowledge about such use, the 
aim of the study reported here was to collect data about species used for therapeutic 
purposes, the purposes for which they are used, which parts of the plants are used, and 
how often they are used. Another aim was to disseminate accurate information about the 
correct and safe use of plant species to individuals of the communities where the study 
was conducted.  
 
2 METHODS 
The study was conducted in the Brazilian cities of Manoel Viana and São 
Francisco de Assis, both in the Valley of Jaguari region. On the western border of the 
state of Rio Grande do Sul, Manoel Viana and São Francisco de Assis have areas of 1,391 
km2 and 2,504 km2 and populations of 7,074 and 19,382 inhabitants, respectively (IBGE, 
2010).  
The study involved interviews with 205 inhabitants of the two cities. Before 
interviews were conducted, each interviewee received an informed consent form, and 
during interviews, he or she responded to open and closed questions presented performed 
by the interviewer, where responses were recorded in a spreadsheet. The questionnaire 
items collected the interviewee’s personal demographic information (i.e., name, age, 
gender, level of education achieved, city of residence, and number of people living in his 
or her residence) and, in the following series of 10 questions, his or her knowledge and 
use of local medicinal plants:  
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a) Do you have any chronic illnesses? If so, then which ones? 
b) What medicines do you use? 
c) Do you know any medicinal plants? If yes, then please name them. 
d) Do you use teas or herbs? 
e) What do you call the medicinal plant(s) that you use? 
f) Which parts of the plant are used: the leaves, stems, roots, fruit, flowers, or 
something else? 
g) What is the purpose of using them? 
h) How often do you use them? 
i) How do you prepare the plants for use as medicine? 
j) Where do you acquire the plants? 
 
After interviews were conducted, the responses were evaluated to identify 
possible drug interactions between the described plants and the pharmaceuticals that 
interviewees mentioned administering. Data regarding drug interactions was collected 
from scientific literature gathered from the electronic databases (Google Acadêmico, 
LILLACS, Scielo e Science Direct). Data analysis was performed with Excel (Microsoft, 
Redmond, WA, U.S.A.). 
The study was approved by the Research Ethics Committee of the Universidade 
Regional Integrada do Alto Uruguai e das Missões (URI), Santiago Campus (no. 
1.769.151). 
 
3. RESULTS 
 From January to June 2017, 205 interviews were conducted in Manoel Viana, RS, 
and São Francisco de Assis, RS. Of the respondents, most were women 79.02% (n = 162), 
and by age, 56–65-year-olds (27.31%) were the most common, followed by 66–75-year-
olds (19.51%). By level of education attained, most interviewees had attended primary 
school (complete: n = 35, 17.07%; incomplete: n = 99, 48.29%). More than a third of 
interviewees (n = 74 36.09%) lived with only one other person; all other proportions of 
interviewees who lived alone or with two or more other people were less. The 
demographic data of the interviewees appear in Table I. 
 
 
 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 5, p.  4129-4144  sep./out. 2019.   ISSN 2595-6825 
 
 
4149  
Table I. Demographic data of interviewees 
Gender 
 
Woman 
n 
162 
% 
79.02 
Man 43 20.97 
Age (in years) 
 n % 
18-25 7 3.41 
26-35 17 8.29 
36-45 29 14.14 
46-55 33 16.09 
56-65 56 27.31 
66-75 40 19.51 
76-85 24 11.70 
Level of education attained 
 n % 
Primary school (complete) 35 17.07 
Primary school (incomplete) 99 48.29 
High school (complete) 33 16.09 
High school (incomplete) 12 5.85 
University (complete) 18 8.78 
University (incomplete) 8 3.90 
Number of people in the residence 
 n % 
1 person 33 16.09 
2 person 74 36.09 
3 person 59 28.78 
4 person 20 9.75 
5 person 17 8.29 
6 person or more 2 0.97 
 
 The majority of interviewees (n = 170, 82.93%) had at least one chronic 
disease. The most common pathologies were arterial hypertension, depression, and 
dyslipidemia (Table II), and some interviewees had more than one pathology 
concurrently. 
  
Table II. Chronic diseases reported by interviewees 
Disease n % 
Arterial hypertension 76 33.04 
Depression 37 16.08 
Dyslipidemia 31 14.47 
Diabetes mellitus 21 9.13 
Vascular disease 17 7.40 
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Hypothyroidism 
Osteoporosis 
Ulcer or gastritis 
11 
6 
5 
4.78 
2.60 
2.17 
Rheumatic disease 4 1.74 
Respiratory disease 4 1.74 
Labyrinthitis 
Arthritis 
Hormonal disorder 
Alzheimer’s disease 
Epilepsy 
Benign prostatic hyperplasia 
Chronic obstructive pulmonary disease 
Spinal condition 
4 
4 
3 
2 
2 
1 
1 
1 
1.74 
1.74 
1.30 
0.87 
0.87 
0.43 
0.43 
0.43 
 
Nearly all interviewees (n = 201, 98.04%) reported using medicinal plants in teas. 
They named 60 species (Table III) that they used in teas, either alone or with up to four 
other species. The total number of plant citations by the sample was 396, or approximately 
1.93 plants per interviewee. 
 
Table 3. Medicinal plants used by interviewees 
Brazilian folk 
name 
Scientific name Plant part n % 
Marcela Achyrocline satureioides          Flowers
 54
 26.86 
54 26.86 
Boldo Peumus boldus Molina Leaves 53 26.36 
Camomila Chamomilla recutita Flowers 29 14.42 
Capim-limão Cymbopogon citratus 
(DC) 
Leaves 23 11.44 
Melissa Melissa officinalis L. Leaves 19 9.45 
Alcachofra Cynara scolymus L. Leaves 13 6.46 
Erva doce Pimpinella anisum L. Seeds 13 6.46 
Chá verde Camellia sinensis Leaves 11 5.47 
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Funcho Foeniculum vulgare Leaves and 
seeds 
11 5.47 
Carqueja Baccharis trimera Leaves 10 4.97 
Gengibre Zingiber officinale Roots 9 4.47 
Alecrim Rosmarinus officinalis L. Leaves 8 3.98 
Hortelã Mentha spp. Leaves 7 3.48 
Guabiroba Campomanesia 
xanthocarpa 
Leaves 7 3.48 
Espinheira santa Maytenus aquifolium Leaves 7 3.48 
Pata de vaca Bauhinia spp. Leaves 7 3.48 
Cavalinha Equisetum arvense L. Stalks 7 3.48 
Laranjeira Citrus sinensis Leaves 6 2.98 
Cidrozinho Aloysia triphylla Leaves 6 2.98 
Limeira Citrus aurantifolia Leaves 6 2.98 
Jurubeba Solanum paniculatum Leaves 6 2.98 
Cambará Lantana camara L. Leaves 5 2.48 
Hibisco Hibiscus sabdariffa L. Flowers 5 2.48 
Insulina Sphagneticola trilobata Leaves 5 2.48 
Anis Apium leptophyllum Flowers 4 1.99 
Ipê roxo Tabebuia heptaphylla Stalks 4 1.99 
Luceira Pluchea sagittalis Leaves 4 1.99 
Picão Acanthospermum 
australe 
Roots 4 1.99 
Pronto-alívio Achillea millefolium Leaves 4 1.99 
Malva Malva sylvestris Leaves 4 1.99 
Sálvia Salvia officinalis Leaves 4 1.99 
Amoreira Morus celtidifolia Leaves 3 1.49 
Guaco Mikania glomerata Leaves 3 1.49 
Chá preto Camellia sinensis Leaves 3 1.49 
Gervão Stachytarpheta 
cayennensis 
Leaves 2 0.99 
Sene Senna alexandrina Leaves 2 0.99 
Tanchagem Plantago major L. Leaves 2 0.99 
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Anis estrelado Illicium verum Flowers 2 0.99 
Maçã Malus domestica Peel 2 0.99 
Quebra-pedra Phyllanthus niruri Leaves 2 0.99 
Cipó-cravo Tynnanthus fasciculatus Stalks 1 0.49 
Aspirina caseira Not identified Leaves 1 0.49 
Espinho de carneiro Xanthium cavanillesii Roots 1 0.49 
Urtigão Urera baccifera L. Roots 1 0.49 
Eucalipto Eucalyptus globulus Leaves 1 0.49 
Poejo Mentha pulegium L. Leaves 1 0.49 
Cipó mil homens Aristolochia elegans Stalks 1 0.49 
Salsaparrilha Smilax aspera Leaves 1 0.49 
Flor de piedra Usnea hieronymi Leaves 1 0.49 
Sucupira Pterodon emarginatus Seeds 1 0.49 
Alfazema Lavandula angustifolia Leaves 1 0.49 
Sabugueiro Sambucus nigra Leaves 1 0.49 
Erva-de-passarinho Struthanthus flexicaulis Leaves 1 0.49 
Canela Cinnamomum verum Stalks 1 0.49 
Alevante Mentha viridis Leaves 1 0.49 
Abacateiro Persea americana Leaves 1 0.49 
Bálsamo do campo Sedum dendroideum Leaves 1 0.49 
Erva mate Ilex paraguariensis Leaves 1 0.49 
Graviola Annona muricata Leaves 1 0.49 
Bergamota Citrus deliciosa Tenore Leaves 1 0.49 
n = number of participants who cited the plant 
 
 The plants most cited by interviewees were A. satureioides (26.86%) and P. 
boldus Molina (26.36%), followed by C. recutita (14.42%) and C. citratus (11.44%), as 
shown in Table III. Regarding parts of the plants used for the preparation of teas, most 
participants reported using leaves (57.80%), followed by flowers (28.27%), seeds 
(4.51%), stalks (4.51%), roots (4.10%), and peel (0.81%).  
 Most interviewees used medicinal plants for digestive and calming purposes 
(26.40% and 19.60%, respectively). Additionally, as results in Table IV show, several 
interviewees (5.17%) mentioned using medicinal plants to aromatize their chimarrão, a 
traditional drink made with yerba mate (I. paraguariensis) by using water of a 
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temperature of approximately 80 °C and ingested from a pot made of porongo (Da Croce 
and Floss, 1999; Maccari Junior, 2005). 
 
Table IV: Final use of plants mentioned by participants 
Final use n % Most used plants 
Digestive 97 26.4% P. boldus, A. satureioides, C. scolymus, B. trimera  
Soothing agent  
Stomach pain 
Flu or cold 
72 
38 
30 
19.6% 
10.3% 
8.17% 
C. citratus, M. offinallis, P. anisum, C. recutita 
P. boldus, A. satureioides, C. citratus, M. aquifolium  
C. sinensis, C. aurantiifolia, C. deliciosa Ten. 
Preparation of 
chimarrão 
Antiflatulent 
Anti-infective 
No final use 
19 
13 
11 
11 
5.17% 
3.54% 
2.99% 
2.99% 
 P. boldus, A. satureioides  
F. vulgare, P. anisum 
T. heptaphylla, A. australe, M. sylvestris, E. arvense 
A. triphylla, C. Sinensis 
Diuretic 
Weight loss 
10 
10 
2.72% 
2.72% 
C. sinensis, M. celtidifolia, Bauhinia sp  
M. aquifolium, B. trimera, Z. officinale 
Antidiabetic 7 1.90% Bauhinia spp., M. pulegium 
Urinary infection 7 1.90% E. arvense 
Hypocholesterolemic 
Cough 
7 
5 
1.90% 
1.36% 
C. xanthocarpa 
M. glomerata  
Liver problems 
Prostate disease 
Sore throat 
Anti-inflammatory 
4 
4 
4 
3 
1.09% 
1.09% 
1.09% 
0.81% 
B. trimera  
U. baccifera  
S. officinalis 
P. emarginatus, M. celtidifolia 
Headache 
Depurative blood 
Antioxidant 
Laxative 
Kidney stones 
Fever 
Rhinitis 
Labyrinthitis 
Vermifuge 
3 
2 
2 
2 
1 
1 
1 
1 
1 
0.81% 
0.54% 
0.54% 
0.54% 
0.27% 
0.27% 
0.27% 
0.27% 
0.27% 
R. officinalis, C. sinensis, A. millefolium 
 M. celtidifolia, S. flexicaulis 
Mentha spp., I. paraguariensis 
S. alexandrina 
U. hieronymi 
Sambucus nigra 
P. major  
R. officinalis  
Mentha spp. 
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Sinusitis  1 0.27% Eucalyptus globules 
n = number of interviewees who reported  
 
 The frequency of the use of medicinal plants among the interviewees was 
moderate (Table V), for the vast majority used medicinal plant species only when 
necessary or about 3 times a week (48.74% and 18.86%, respectively). 
 
Table V: Frequency of use of medicinal plants among interviewees 
Frequency of use % 
Daily 9.43% 
1 time per week 14.77% 
2 times per week 5.08% 
3 times a week or more 18.86% 
When necessary 48.74% 
 
 For the preparation of the teas, roughly 72% of the interviewees used infusion, 
whereas roughly 28% used decoction. Some interviews required explaining the difference 
between the types of extraction for teas to prevent confusion among interviewees. Most 
medicinal plant species used were obtained from home gardens (67.90%), markets 
(30.23%), pharmacies (1.40%), and fairs (0.47%). 
 Most interviewees reported continually using some type of pharmaceutical agent 
(87.3%); the most commonly mentioned were diuretics, antihypertensives, 
hypocholesterolemics, hypoglycemics, nutritional supplements, and hormones. All 
pharmaceuticals cited appear in Table VI.  
 
Table VI. Pharmaceuticals continually used by interviewees 
Drug n % 
Hydrochlorothiazide 51 12.97% 
Losartan 32 8.14% 
Simvastatin 30 7.63% 
Metformin 21 5.34% 
Atenolol 19 4.83% 
Calcium carbonate + vitamin 
D 
19 4.83% 
Enalapril 16 4.07% 
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Levothyroxine sodium 
Omeprazole 
Clonazepam 
Glibenclamide 
Sodium alendronate 
Captopril 
Fluoxetine 
Acetylsalicylic acid 
Sertraline 
Amlodipine 
Oral contraceptive 
Diazepam 
Escitalopram 
Rosuvastatin 
Amitriptyline 
Clopidogrel 
14 
13 
10 
9 
6 
6 
6 
6 
6 
5 
5 
5 
5 
5 
4 
4 
3.56% 
3.3% 
2.54% 
2.29% 
1.52% 
1.52% 
1.52% 
1.52% 
1.52% 
1.27% 
1.27% 
1.27% 
1.27% 
1.27% 
1.01% 
1.01% 
Omega-3 
Pantoprazole 
Propranolol 
Venlafaxine 
3 
3 
3 
3 
0.76% 
0.76% 
0.76% 
0.76% 
Indian chestnut 
Alprazolam 
Amiodarone 
Betahistine 
Bromazepam 
Caverdilol 
Cilostazol 
Ergoloid 
Diosmin + hesperidin 
Duloxetine 
Flunarizine 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
0.5% 
0.5% 
0.5% 
0.5% 
0.5% 
0.5% 
0.5% 
0.5% 
0.5% 
0.5% 
0.5% 
Budesonide + formoterol 2 0.5% 
Glimepiride 
Glucosamine + chondroitin 
Leflunomide 
Memantine 
2 
2 
2 
2 
0.5% 
0.5% 
0.5% 
0.5% 
Ramipril 2 0.5% 
Valproic acid 
Budesonide 
Carbamazepine 
1 
1 
1 
0.25% 
0.25% 
0.25% 
Lithium carbonate 
Cyclobenzaprine 
1 
1 
0.25% 
0.25% 
Amiloride + chlorthalidone 1 0.25% 
Cloxazolam 1 0.25% 
Coumarin + troxerutin 1 0.25% 
Diclofenac sodium 
Domperidone 
Donepezil 
Doxazosin + finasteride 
Dutasteride + tamsulosin 
1 
1 
1 
1 
1 
0.25% 
0.25% 
0.25% 
0.25% 
0.25% 
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Spironolactone 
Spironolactone + HCTZ 
1 
1 
0.25% 
0.25% 
Estradiol 
Conjugated estrogens 
Fenofibrate 
Flunitrazepam 
1 
1 
1 
1 
0.25% 
0.25% 
0.25% 
0.25% 
Furosemide 
Ginkgo biloba 
1 
1 
0.25% 
0.25% 
Amiloride + HCTZ 
Insulin 
Isosorbide 
1 
1 
1 
0.25% 
0.25% 
0.25% 
Levomepromazine 
Losartan + amlodipine 
Methyldopa 
Metoprolol 
Beclomethasone 
1 
1 
1 
1 
1 
0.25% 
0.25% 
0.25% 
0.25% 
0.25% 
Mirtazapine 
Olmesartan 
1 
1 
0.25% 
0.25% 
Acetaminophen + codeine 1 0.25% 
Piracetam 
Prednisone 
Promethazine 
Propatylnitrate 
1 
1 
1 
1 
0.25% 
0.25% 
0.25% 
0.25% 
Fluticasone propionate 
Propranolol + HCTZ 
1 
1 
0.25% 
0.25% 
Risperidone 1 0.25% 
piracetam + cinnarizine 
Sitagliptin + metformin 
1 
1 
0.25% 
0.25% 
Sulfasalazine 1 0.25% 
Sulpiride 
Tamoxifen 
Tibolone 
Topiramate 
1 
1 
1 
1 
0.25% 
0.25% 
0.25% 
0.25% 
Tramadol + acetaminophen 
Warfarin 
Verapamil 
1 
1 
1 
0.25% 
0.25% 
0.25% 
Zolpidem 1 0.25% 
 
4. DISCUSSION 
According to Brunello et al. (1998), the most common chronic diseases in elderly 
individuals are respiratory disease, cardiovascular disease, renal impairment, arthritis, 
psychological disorders (e.g., anxiety and depression), and endocrine disease (e.g., type 
2 diabetes). By little contrast, the most prevalent chronic diseases experienced by 
interviewees in the study reported here, slightly less than half of whom were aged either 
56–65 years (27.31%) or 66–75 years (19.51%, Table I), were hypertension (33.04%), 
depression (16.08%), and dyslipidemia (14.47%), as detailed in Table II. The age 
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distribution of interviewees (Table I) was similar to that of samples in the 
ethnopharmacological studies of Battisti et al. (2013), in which 67% of respondents were 
older than 55 years, and Vendrúsculo and Mentz (2006), in which the representative age 
group was 40–70 years old. Generally, older individuals tend to use medicinal plants more 
often than younger ones because they retain traditional knowledge about plants for 
treating health conditions (Battisti et al., 2013). 
The prevalence of women in the study (79.02%, Table I) was also evidenced in 
ethnopharmacological studies in the cities of Palmeira das Missões and Porto Alegre 
(Battisti et al., 2013; Vendrúculo and Mentz, 2006). 
In Brazil, about 82% of the population uses medicinal herbal products in their 
healthcare (Rodrigues and De Simoni, 2010). Likewise, an extremely high plant use index 
was observed in the cities of Manoel Viana and São Francisco de Assis, where 98.04% 
of the 205 interviewees reported using medicinal plants. 
The plants that interviewees indicated using most often were Achyrocline 
satureioides (26.86%) and Peulmus boldus Molina (26.36%), followed by Chamomilla 
recutita (14.42%), Cymbopogon citratus (DC) (11.44%), and Melissa officinalis L 
(9.45%). Those same plants were also cited in ethnopharmacological studies conducted 
in other cities in southern Brazil, including Palmeira das Missões (Battisti et al., 2013), 
Porto Alegre (Vendrúsculo and Mentz, 2006), São Luiz Gonzaga (Barros et al., 2002), 
and Uruguaiana (Galvani and Barreneche, 1994). 
In the preparation of teas, interviewees cited using medicinal plant leaves more than 
any other part of the plants. The same tendency characterized a sample of the population 
in Palmeira das Missões (Battisti et al., 2013). The relative ease of acquiring leaves could 
explain their common use in teas, as could their availability throughout the year compared 
to other parts of plants, including fruits, seeds, and flowers, that are not available year-
round (Castellucci et al., 2000, Vásques et al., 2014). The use of aerial parts of plants also 
preserves individual plants and the species (Coan and Matias, 2013), for the use of roots 
and stalks requires removing plants from their habitat and, inevitably, plant death. 
Interviewees most often reported using medicinal plants to treat digestive 
conditions (26.4%), which corresponds to results obtained in Palmeira das Missões, Porto 
Alegre, and Uruguaiana (Battisti et al., 2013; Vendrúsculo and Mentz, 2006; Galvani and 
Barreneche, 1994). Other oft-mentioned uses were as soothing agents (19.6%) and as 
flavoring agents for chimarrão (5.17%, Table IV), as also found in the city of Uruguaiana 
(Galvani and Barreneche, 1994). 
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The vast majority of interviewees (72%) reported preparing teas by infusion, 
whereas only slightly more than a fourth (28%) reported using decoction. In infusing teas, 
the extraction of medicinal properties occurs via the direct contact of the plant material 
with boiling water in a covered container, whereas in decoction the plant material has to 
stay in contact with the liquid extractor in boiling water for a certain amount of time. 
Infusing teas is recommended for plant parts with soft structure such as leaves, flowers, 
and inflorescences. Since interviewees reported using leaves most often in preparing teas, 
their reliance on extraction via infusion is appropriate. By contrast, decoction should be 
used for hard materials such as rhizomes and roots (Simões et al., 2010). Tea preparation 
by infusion and decoction also dominated in the results of ethnopharmacological studies 
conducted in Palmeira das Missões (Battisti et al., 2013) and Porto Alegre (Vendrúsculo 
and Mentz, 2006).  
The cultivation and acquisition of medicinal plants in home gardens was often 
reported by interviewees (67.8%), as was also the case in a study conducted in the city of 
São Luiz Gonzaga (Barros et al., 2007). That tendency is somewhat worrisome, since the 
risk of toxicity by using misidentified plants is significant when populations are not 
trained in plant identification and thus liable to confuse one plant with another. Also 
troubling is the possibility of having two plant species with the same popular name in the 
same ecosystem (Simões et al., 2010), which involves the risk of using medicinal plants 
for unintended purposes. The toxicity of plants whose use lacks pharmacological 
evidence can negatively affect users without knowledge of the effects of plant–drug 
interactions, as in the case of allopathic medications (Veiga Junior, 2008). 
The pharmaceuticals most cited by interviewees (Table VI) were 
hydrochlorothiazide (i.e., a thiazide diuretic), losartan (i.e., an angiotensin receptor 
antagonist), simvastatin (i.e., a coenzyme A inhibitor), metformin (i.e., sulfonylurea), and 
atenolol (i.e., a beta blocker; Korolkovas, 2009), which is consistent with the chronic 
diseases most cited by interviewees: hypertension, dyslipidemia, and diabetes (Table II). 
Participants in a study conducted in São Luiz Gonzaga, most of them elderly and who 
tended to use pharmaceuticals to treat specific pathologies, also reported using medicinal 
plants in complementary therapy (Barros et al., 2007). That tendency is problematic, since 
the interaction of medicinal plant constituents with pharmaceutical products may cause 
intoxication instead of the expected benefits (Barros et al., 2007). 
Several interactions can occur when using medicinal plants concomitantly with 
pharmaceutical products that can cause serious harm to users, including impaired 
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recovery (Nicoletti et al., 2010). Such interactions can prompt pharmacological changes 
and alter the toxicity of drugs in three ways; one could potentiate the action of another, 
conflicting actions could render them ineffective, and a drug’s action could alter the 
absorption, excretion, or intra-organism transformation of another drug (Futuro et al., 
2004; Oliveira and Dalla Costa, 2004). 
The medicinal plants most cited by interviewees were evaluated against their main 
drug interactions. First, A. satureioides, used to aid digestion, to treat intestinal colic, and 
as a mild sedative (Brasil, 2010), has hypotensive effects (Souza and Felfilli, 2006) and 
should thus be used with caution by patients who are concurrently using 
antihypertensives. That interaction may benefit sufferers of hypertension; however, the 
plant should be used with caution to avoid serious hypotension. High blood pressure was 
the most-cited disease (33.04%) among interviewees (Table 2), and several of them 
reported using antihypertensives such as losartan, atenolol, enalapril, and captopril (Table 
VI). 
 Second, P. boldus Molina can interact with anticoagulants and antiplatelets such 
as acetylsalicylic acid, clopidogrel, and warfarin. The species can intensify the action of 
those drugs since its secondary metabolite, boldine, blocks platelet aggregation (Nicoletti, 
2012). Interviewees sometimes reported using such anticoagulants and antiplatelets, 
especially acetylsalicylic acid (1.52%), clopidogrel (1.01%), and warfarin (0.25%), as 
shown in Table VI. 
 Third, M. recutita can also interact with anticoagulants and antiplatelets (e.g., 
warfarin and clopidogrel) and thereby raise the risk of bleeding. The plant can 
additionally interact with barbiturates and other central nervous system (CNS) 
depressants (e.g., phenobarbital), with the effect of increasing or prolonging the 
depressant action of the CNS (Nicoletti, 2012). Moreover, the plant can interact with 
nonsteroidal anti-inflammatory drugs and thereby increase the risk of bleeding. Its 
interactions with statins and oral contraceptives have also been described (Nicoletti, 2012; 
Smeriglio et al., 2014; Szafrański, 2014). Interviewees sometimes reported suffering from 
dyslipidemia (14.47%, Table II), as well as using simvastatin to treat it (7.63%, Table 
VI). 
 Fourth, C. citratus, due to its sedative action and spasmolytic activity, should be 
used cautiously with sedative drugs, the effects of which it can potentiate (Matos, 2002; 
Brasil, 2011). At the same time, using antihypertensive agents in conjunction with the 
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plant can increase the risk of hypertension. Notably, certain interviewees reported using 
sedative drugs as well as antihypertensive ones (Table VI). 
Fifth, M. officinalis L. can interact with other medicines containing medicinal 
plants, specifically those with kava kava (Piper methysticum). Thus, the plant also 
interacts with CNS depressants (e.g., diazepam) and thyroid hormones (e.g., 
levothyroxine sodium), as Cardoso et al. (2009) have described. Some interviewees cited 
using those drugs to treat their illnesses (Table VI). 
Sixth, users of C. scolymus should not use loop diuretics (e.g., furosemide) or 
thiazide (e.g., hydrochlorothiazide) in teas made with the plant. The plant can drastically 
reduce blood volume and thus blood pressure via hypovolemia, which entails the massive 
excretion of potassium (Cardoso et al., 2009). One interviewee mentioned using 
furosemide (0.58%), whereas hydrochlorothiazide was the drug most cited by the sample 
(n = 51, 12.97%), as shown in Table VI. 
Seventh, P. anisum can prolong the action of hypnotic and sedative medications 
and, due to mild estrogenic effects, also interfere with the effect of oral contraceptives 
(Nicoletti, 2012; Williamson et al., 2012). Clonazepam was the most-cited sedative and 
hypnotic medication by interviewees (2.54%), while others reported the use of 
contraceptives (1.27%), as shown in Table VI. 
Eighth, using C. sinensis can decrease lithium levels and increase blood pressure 
when used simultaneously with metoprolol or propranolol (Cardoso et al., 2009). Because 
the plant has significant amounts of caffeine, it can moderately increase blood pressure 
and thereby impair treatments performed to control hypertension (Williamson et al., 
2012). Notably, hypertension was the most-cited pathology among interviewees (33.04%, 
Table II), and propranolol was cited among the drugs used continually (0.76%, Table VI). 
Ninth, F. vulgare has carminative, antispasmodic, expectorant, and antiflatulent 
actions (Alexandrovich et al., 2003; Simões et al., 2010). If used together with 
barbiturates, then the plant can potentiate the effects of those drugs (Londrina, 2006). 
Studies have shown a possible interaction between ciprofloxacin (antibiotic) and F. 
vulgare that decreases plasma concentrations of the drug (Zhu et al., 1999). 
Tenth and last, B. trimera, when used with antihypertensives, can increase the 
action of those drugs and cause hypotension (Alonso and Desmarchelier, 2006). 
Moreover, because the plant has hypoglycemic activity (Oliveira et al., 2005), it should 
be used with caution among patients who take antidiabetic medication. Diabetes ranked 
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among the diseases most reported by interviewees (9.13%, Table II), and metformin was 
the most-cited drug for the treatment of that pathology (5.34%, Table VI). 
 
5. CONCLUSION 
The results indicate that communities in São Francisco de Assis, RS, and Manoel 
Viana, RS, frequently use medicinal plants, mainly in the form of teas, as well as various 
types of medications. The plants most cited by residents of those cities were A. 
satureioides, P. boldus Molina, C. recutita, C. citratus, C. scolymus L., P. anisum L., F. 
vulgare, and B. trimera. 
Among the medicinal plants that interviewees reported using most often, the great 
majority present the potential to interact with pharmaceuticals also taken by the 
interviewees. That those medicinal plants are considered to be natural products does not 
mean that they are exempt from interacting with medications and can cause innumerable 
harm to users. 
Knowledge about plants is transferred from generation to generation, as well as 
spreads among people in communities and throughout societies. The popular knowledge 
demonstrated in this ethnopharmacological study strengthens the merit that medicinal 
plants have in the palliative or curative therapy of diseases. 
REFERENCES 
 
ALEXANDROVICH, I; RAKOVITSKAYA, O; KOLMO, E; SIDOROVA, T; 
SHUSHUNOV, S. The effect of fennel (Foeniculum vulgare) seed oil emulsion in infatile 
colic: a radomized, placebo- controlled study. Altern. Ther. Health Med, v. 9, p. 58-61, 
2003. 
 
ALONSO, J; DESMARCHELIER, C. Plantas medicinales autóctonas de la 
Argentina. Bases científicas para su aplicación en atención primaria de la salud. 
Buenos Aires: LOLA, 2006, 663p. 
 
BARBOSA, S.N.C. Uso de plantas medicinais na comunidade quilombola da Barra II- 
Bahia, Brasil. Boletín Latinoamericano y del Caribe de Plantas Medicinales y 
Aromáticas,  v. 11, n. 5, p. 435-453, 2012. 
 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 5, p.  4129-4144  sep./out. 2019.   ISSN 2595-6825 
 
 
4162  
BARROS, F.M.C; PEREIRA, K.N; ZANETTI, G.D; HEINZMANN, B.M. Plantas de 
uso medicinal no município de São Luiz Gonzaga. Latin American Journal of 
Pharmacy, v. 26, n. 10, p. 652-662, 2007. 
 
BATTISTI, C; GARLET, T.M.B; ESSI, L; HORBACH, R.K; ANDRADE, A; BADKE, 
M.R. Plantas medicinais utilizadas no município de Palmeira das Missões, RS, Brasil. 
Revista Brasileira de Biociências, v. 11, n. 3, p. 338-348, 2013. 
 
BRASIL. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução - RDC nº 10, 
de 9 de março de 2010. Dispõe sobre a notificação de drogas vegetais junto à Agência 
Nacional de Vigilância Sanitária (ANVISA) e dá outras providências. Diário Oficial da 
República Federativa do Brasil, Poder Executivo, Brasília, DF, 10 mar. 2010. Seção 1, p. 
52-59. 
 
BRASIL. Agência Nacional de Vigilância Sanitária. Formulário de Fitoterápicos da 
Farmacopéia Brasileira/Agência Nacional de Vigilância Sanitária. Brasília: Anvisa, 
2011. 
 
BRUNELLO D.L; MANDIKOS M.N. Construction faults, age, gender and relative 
medical health: factors associated with complaints in complete denture patients. J 
Prosthet Dent., v. 79, n .10, p. 545-554, 1998. 
 
CAPASSO, R; IZZO, A.A; PINTO, L; BIFULCO, T; VITOBELLO, C; MASCOLO, N. 
Phytotherapy and quality of herbal medicines. Fitoterapia, v. 71, n. 3, p. 58-65, 2000. 
 
CARDOSO, C. M. Z. et al. Elaboração de uma cartilha direcionada aos profissionais da 
Área da Saúde, Contendo Informações sobre Interações Medicamentosas envolvendo 
Fitoterápicos e Alopáticos. Revista Fitos, v. 4, n. 13, p. 56-69, 2009. 
 
CASTELLUCCI, S. et. al. Plantas medicinais relatadas pela comunidade residente na 
Estação Ecológica de Jataí, município de Luís Antonio – SP: uma abordagem 
etnobotânica. Revista Brasileira de Plantas Medicinais, v. 3, p. 51-60, 2000. 
 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 5, p.  4129-4144  sep./out. 2019.   ISSN 2595-6825 
 
 
4163  
COAN, C. M; MATIAS, T. A utilização das plantas medicinais pela comunidade 
indígena de Ventarra Alta- RS. Revista de educação do IDEAU, v. 8, n. 18, p. 11-19, 
2013. 
 
COELHO, F.B.R; DAL BELO, C.A; LOLIS, S.F; SANTOS, M.G. Levantamento 
etnofarmacológico realizado na comunidade mumbuca localizada no Jalapão- TO. 
Revista Eletrônica de Farmácia Suplemento, v. 2, n. 2, p. 52-55, 2005. 
 
DA CROCE, D.M; FLOSS, P.A. Cultura da erva-mate no Estado de Santa Catarina. 
Florianópolis, SC: EPAGRI - Empresa de Pesquisa Agropecuária e Difusão de 
Tecnologia de SC. 81p. EPAGRI, Boletim Técnico:100, 1999. 
 
FUTURO, D. O; FIORINI, F. S; CASTILHO, S. R. Interações entre Plantas e 
Medicamentos. Informativo CEATRIM, n. 3, 2004. Disponível em http://www.crf-
rj.org.br/crf/infor/cetrim/arquivos/200412_CEATRIM.pdf. Acesso em 15/05/2018.  
 
IBGE – Instituto Brasileiro de Geografia e estatística. Dados sobre as cidades 
Brasileiras. Disponível em: 
<http://www.cidades.ibge.gov.br/xtras/perfil.php?lang=&codmun=431175&search=||inf
ogr%E1ficos:-informa%E7%F5es-completas>. Acesso em: 03/05/2018. 
 
VEIGA JUNIOR, V.F. Estudo do consumo de plantas medicinais da Região Centro-Norte 
do Rio de Janeiro: Aceitação pelos profissionais de saúde e modo de uso pela população. 
Revista Brasileira de Farmacognosia, v. 18, n. 6, p. 308-313, 2008. 
 
KOROLKOVAS, A., 2009. Dicionário Terapêutico Guanabara. 16st edição. Rio de 
Janeiro: Guanabara Koogan, 686p. 
 
LONDRINA: MUNICÍPIO DE LONDRINA-PR. Fitoterapia: Protocolo da Prefeitura 
do Município de Londrina, PR. Autarquia Municipal de Saúde. 1st ed., Londrina, PR: 
[s.n.], 2006. 
 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 5, p.  4129-4144  sep./out. 2019.   ISSN 2595-6825 
 
 
4164  
MACCARI JUNIOR, A. Análise do pré-processamento da erva-mate para 
chimarrão. 215p. Tese (Doutorado em Engenharia Agrícola) – Curso de Engenharia 
Agrícola, UNICAMP. Campinas, 2005. 
 
MATOS, F. J. A. Farmácias vivas: sistema de utilização de plantas medicinais − 
projeto para pequenas comunidades. 4. ed. Fortaleza: Editora UFC, 2002. 
 
MENGUE, S. S; MENTZ, L. A; SCHENKEL, E. P. Uso de plantas medicinais na 
gravidez. Revista Brasileira de Farmacognosia, v. 11, n. 1, p. 21-35, 2001. 
 
MOREIRA, F. V. Chemical composition and cardiovascular effects induced by the 
essential oil of Cymbopogon citratus DC. Stapf, Poaceae, in rats. Brazilian Journal of 
Pharmacognosy, v. 20, n. 6, p. 904-906, 2010. 
 
NICOLETTI, A. M. et al. Uso popular de medicamentos contendo drogas de origem 
vegetal e/ou plantas medicinais: principais interações decorrentes. Revista saúde, v. 4, n. 
1, p. 25-39, 2010. 
 
NICOLETTI, M.A. et al. Fitoterápicos – Principais Interações Medicamentosas. São 
Paulo: ASSOCIAÇÃO NACIONAL DE FARMACÊUTICOS MAGISTRAIS - Brasil, 
1.ed, 118p, 2012. 
 
NIEHUES, J. et al. Levantamento etnofarmacológico e identificação botânica de plantas 
medicinais em comunidades assistidas por um serviço de saúde. Arquivos Catarinenses 
de Medicina, v. 40, n. 6, p. 34-39, 2011. 
 
OLIVEIRA, A. E; DALLA COSTA, T. Interações farmacocinéticas entre as plantas 
medicinais Hypericum perforatum, Gingko biloba e Panax gingseng e Fármacos 
Tradicionais. Acta Farmacéutica Bonaerense, v. 23, n. 4, p. 567-578, 2004. 
 
OLIVEIRA, A.C; ENDRINGER, D.C; AMORIM, L.A; DAS GRAÇAS, 
L.B.M; COELHO, M.M. Effect of the extracts and fractions of Baccharis trimera and 
Syzygium cumini on glycaemia of diabetic and non-diabetic mice. Journal of 
Ethnopharmacology, v. 102, n. 3, p. 465-69, 2005. 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 5, p.  4129-4144  sep./out. 2019.   ISSN 2595-6825 
 
 
4165  
 
Oliveira, C. J; Araújo, T. L. Plantas medicinais: usos e crenças de idosos portadores de 
hipertensão arterial. Revista Eletrônica de Enfermagem, v. 9, n. 1, p. 93-105, 2007. 
 
RITTER, M.R; SOBIERAJKI, G.R; SCHENKEL, E.P; MENTZ, L.A. Plantas usadas 
como medicinais no município de Ipê, RS, Brasil. Revista Brasileira de 
Farmacognosia, v. 12, n. 2, p. 51-62, 2002. 
 
RODRIGUES, A.G; DE SIMONI, C. Plantas medicinais no contexto de políticas 
públicas. Informe Agropecuário, v. 31, n. 255, p. 7-12, 2010. 
 
SIMÕES, C. M. O; SCHENKEL, E.P; GOSMANN, G;  MELLO, J.C.P;  MENTZ, L.A;  
PETROVICK. P.R. Farmacognosia da planta ao medicamento. 6.ed. Porto 
Alegre:  Editora da UFRGS: Florianópolis: Editora da UFSC, 1104p, 2010. 
   
SMERIGLIO, A; TOMAINO, A; TROMBETTA, D. Herbal products in pregnancy: 
Experimental studies and clinical reports. Phytother Res, v. 28, p. 1107–1116, 2014. 
 
SOUZA, C.D. DE; FELFILI, J.M. Uso de Plantas Medicinais na Região de Alto Paraíso 
de Goiás, Goiás, Brasil. Acta Botânica Brasileira, v. 20, n. 7, p.135-142, 2006. 
 
SZAFRAŃSKI, T. Herbal remedies in depression– state of the art. Psychiatr Pol, v. 48, 
p. 59–73, 2014. 
 
VÁSQUES, S. P. F; MENDONÇA, M. S; DE NODA, S, N. Etnobotânica de plantas 
medicinais em comunidades ribeirinhas do Município de Manacapuru, Amazonas, Brasil. 
Acta Amazonica, v. 44, n. 4, p. 457-472, 2014. 
 
VEIGA JUNIOR, V. F. V; PINTO, A. C; MACIEL, M. A. M. Plantas medicinais: cura 
segura?. Química Nova, v. 28, p. 519-528, 2005. 
 
VENDRÚSCOLO, G.S; MENTZ, L.A. Levantamento etnobotânico das plantas utilizadas 
como medicinais por moradores do bairro Ponta Grossa, Porto Alegre, Rio Grande do 
Sul, Brasil. Iheringia Série Botânica, v. 61, n. 20, p. 83-103, 2006. 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 5, p.  4129-4144  sep./out. 2019.   ISSN 2595-6825 
 
 
4166  
 
WACHTEL-GALOR, S; BENZIE, I. F. F. Herbal Medicine: An Introduction to Its 
History, Usage, Regulation, Current Trends, and Research Needs. 2ª ed. Boca Raton: 
CRC Press, 2011. 
 
WILLIAMSON, E; DRIVER, S; BAXTER, K. Interações Medicamentosas de 
Stockley .1st ed. Porto Alegre: Artmed, 440p, 2012.  
 
ZANCANARO, V. 2007. Fitoterápicos: Automedicação com fitoterápicos, seus 
efeitos adversos e colaterais. Disponível em: 
<http://www.cdr.unc.br/cimunc/docs/pergunta/Fitoterapicos.doc>. Acesso em 
10/04/2018. 
 
ZHU, M; WONG, Y.K; LI, R.C. Effect of oral administration of Fennel (Foeniculum 
vulgare) on ciprofl oxacin absorption and dispo sition in the rat. J Pharm Pharmacol, v. 
5, p. 1391-1396, 1999. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 5, p.  4129-4144  sep./out. 2019.   ISSN 2595-6825 
 
 
4167  
ATTACHMENTS 
Attachment 1 – Questionnaire used for interviews (page 1) 
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Attachment 1 – Questionnaire used for interviews (page 2) 
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Attachment 2 – Free and informed consent form 
 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 5, p.  4129-4144  sep./out. 2019.   ISSN 2595-6825 
 
 
4170  
Attachment 3 – Approval of the work in the Research Ethics Committee of URI Câmpus of 
Santiago. 
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Attachment 3 – Approval of the work in the Research Ethics Committee of URI Câmpus of 
Santiago (Continuation). 
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Attachment 3 – Approval of the work in the Research Ethics Committee of URI Câmpus of 
Santiago (Continuation). 
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Attachment 3 – Approval of the work in the Research Ethics Committee of URI Câmpus of 
Santiago (Continuation). 
 
 
